These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27284531)

  • 1. Are persistent delusions in schizophrenia associated with aberrant salience?
    Abboud R; Roiser JP; Khalifeh H; Ali S; Harrison I; Killaspy HT; Joyce EM
    Schizophr Res Cogn; 2016 Jun; 4():32-38. PubMed ID: 27284531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with schizophrenia exhibit aberrant salience?
    Roiser JP; Stephan KE; den Ouden HE; Barnes TR; Friston KJ; Joyce EM
    Psychol Med; 2009 Feb; 39(2):199-209. PubMed ID: 18588739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Salience Is Related to Dysfunctional Self-Referential Processing in Psychosis.
    Pankow A; Katthagen T; Diner S; Deserno L; Boehme R; Kathmann N; Gleich T; Gaebler M; Walter H; Heinz A; Schlagenhauf F
    Schizophr Bull; 2016 Jan; 42(1):67-76. PubMed ID: 26194892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the construct of aberrant salience in schizophrenia - Behavioral evidence for an automatic process.
    Katthagen T; Dammering F; Kathmann N; Kaminski J; Walter H; Heinz A; Schlagenhauf F
    Schizophr Res Cogn; 2016 Dec; 6():22-27. PubMed ID: 28740821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the construct validity of aberrant salience.
    Schmidt K; Roiser JP
    Front Behav Neurosci; 2009; 3():58. PubMed ID: 20057930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of motivational salience processing during the early stages of psychosis.
    Smieskova R; Roiser JP; Chaddock CA; Schmidt A; Harrisberger F; Bendfeldt K; Simon A; Walter A; Fusar-Poli P; McGuire PK; Lang UE; Riecher-Rössler A; Borgwardt S
    Schizophr Res; 2015 Aug; 166(1-3):17-23. PubMed ID: 25999039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.
    Nagy H; Levy-Gigi E; Somlai Z; Takáts A; Bereczki D; Kéri S
    Neuropsychopharmacology; 2012 Mar; 37(4):950-8. PubMed ID: 22089321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant salience and reward processing: a comparison of measures in schizophrenia and anxiety.
    Neumann SR; Glue P; Linscott RJ
    Psychol Med; 2021 Jul; 51(9):1507-1515. PubMed ID: 32148214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.
    Roiser JP; Howes OD; Chaddock CA; Joyce EM; McGuire P
    Schizophr Bull; 2013 Nov; 39(6):1328-36. PubMed ID: 23236077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive and aberrant reward prediction signals in the human brain.
    Roiser JP; Stephan KE; den Ouden HE; Friston KJ; Joyce EM
    Neuroimage; 2010 Apr; 50(2):657-64. PubMed ID: 19969090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What you want may not be what you like: A test of the aberrant salience hypothesis in schizophrenia risk.
    Li LY; Castro MK; Martin EA
    Cogn Affect Behav Neurosci; 2020 Aug; 20(4):873-887. PubMed ID: 32638159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salience attribution and its relationship to cannabis-induced psychotic symptoms.
    Bloomfield MA; Mouchlianitis E; Morgan CJ; Freeman TP; Curran HV; Roiser JP; Howes OD
    Psychol Med; 2016 Dec; 46(16):3383-3395. PubMed ID: 27628967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationships among aberrant salience, reward motivation, and reward sensitivity.
    Neumann SR; Linscott RJ
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1615. PubMed ID: 29691918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered subcortical emotional salience processing differentiates Parkinson's patients with and without psychotic symptoms.
    Knolle F; Garofalo S; Viviani R; Justicia A; Ermakova AO; Blank H; Williams GB; Arrondo G; Ramachandra P; Tudor-Sfetea C; Bunzeck N; Duezel E; Robbins TW; Barker RA; Murray GK
    Neuroimage Clin; 2020; 27():102277. PubMed ID: 32540629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.
    Schmidt A; Antoniades M; Allen P; Egerton A; Chaddock CA; Borgwardt S; Fusar-Poli P; Roiser JP; Howes O; McGuire P
    Psychol Med; 2017 Jan; 47(2):243-254. PubMed ID: 27697078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyramidal cell-selective GluN1 knockout causes impairments in salience attribution and related EEG activity.
    Forrest AD; Bang J; Featherstone RE; Bloom JH; Luminais MS; Zhang RV; Gajewski CR; McMullen MF; Liang Y; Siegel SJ
    Exp Brain Res; 2018 Mar; 236(3):837-846. PubMed ID: 29350251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant modulation of brain activation by emotional valence during self-referential processing among patients with delusions of reference.
    Girard TA; Lakatos L; Menon M
    J Behav Ther Exp Psychiatry; 2017 Sep; 56():21-26. PubMed ID: 27887704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders.
    Pugliese V; de Filippis R; Aloi M; Rotella P; Carbone EA; Gaetano R; De Fazio P
    Ann Gen Psychiatry; 2022 Jul; 21(1):25. PubMed ID: 35786401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.
    Boehme R; Deserno L; Gleich T; Katthagen T; Pankow A; Behr J; Buchert R; Roiser JP; Heinz A; Schlagenhauf F
    J Neurosci; 2015 Jul; 35(28):10103-11. PubMed ID: 26180188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.
    Esslinger C; Englisch S; Inta D; Rausch F; Schirmbeck F; Mier D; Kirsch P; Meyer-Lindenberg A; Zink M
    Schizophr Res; 2012 Sep; 140(1-3):114-21. PubMed ID: 22784688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.